Date published: 2025-12-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

Stap2 Inhibitors

Chemical inhibitors of Stap2 can exert their inhibitory effects through several mechanisms related to the disruption of signaling pathways. Staurosporine, for instance, is a potent protein kinase inhibitor that can reduce the activation of downstream proteins which Stap2 may require for its function, essentially leading to a decrease in Stap2 activity due to reduced phosphorylation events. Similarly, PP2 specifically targets Src family kinases, which are important for various cell signaling processes, and by inhibiting these kinases, PP2 can diminish the phosphorylation and activation of proteins that are part of Stap2's signaling network. LY294002 and Wortmannin are inhibitors of PI3K, a key kinase in many signaling pathways, and their inhibition is likely to result in a decreased activity of Stap2 by limiting the production of PIP3 and activation of AKT, thereby reducing the downstream signaling events that Stap2 is involved in.

Dasatinib, by targeting Src family kinases, can decrease activation of signaling cascades that are necessary for Stap2's function. Inhibition of JNK by SP600125 may lead to a reduction in the activity of transcription factors that regulate the expression or activity of proteins interacting with or regulating Stap2, thus diminishing its functional output. U0126 and PD98059 interrupt the MEK-ERK signaling axis, which is a critical pathway for the regulation of various cellular functions, including those associated with Stap2. SB203580 targets p38 MAP kinase, which is involved in the response to stress signals that might otherwise activate Stap2. Rapamycin inhibits mTOR, leading to a decrease in signaling processes essential for cell growth and proliferation where Stap2 may play a role. Lastly, inhibitors like Gefitinib and Sorafenib target tyrosine kinases including EGFR and several others, which are upstream of multiple signaling pathways that could involve Stap2, thereby reducing the kinase activity and subsequent signaling necessary for Stap2's function in cellular processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Inhibits multiple protein kinases which could lead to reduced activation of downstream proteins that Stap2 requires for its function.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

Selectively inhibits Src family kinases thereby potentially reducing the phosphorylation of substrates involved in Stap2 signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits PI3K which is upstream in cell signaling pathways that Stap2 may be involved in, leading to a decrease in its functional activity.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Targets Src family kinases and could reduce the activation of signaling cascades that involve Stap2.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, potentially reducing the activity of transcription factors and other proteins that could interact with or regulate Stap2.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Inhibits MEK1/2 leading to decreased ERK pathway activity, which may be necessary for Stap2 functional activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Inhibits p38 MAP kinase, potentially impacting Stap2's role in response to cellular stress signals.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Inhibits PI3K, which is likely to decrease the downstream signaling required for Stap2 activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Inhibits MEK, which may reduce ERK pathway signaling, potentially impacting Stap2 activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR, which could decrease the signaling required for Stap2's role in cell growth and proliferation.